Sort
30,917 grants matching “tumor microenvironment”
Chitinase-3-like-1 mediated immunosuppression in Glioblastoma
$462,773Baoli Hu · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · CA
Optimizing antibody-based therapy through a system platform of pharmacokinetics-pharmacodynamics-immunodynamics
$462,763Yanguang Cao · Univ Of North Carolina Chapel Hill · R35 · FY2018 · GM
Targeting ferroptosis in aggressive subtypes of lung cancer
$462,704Triparna Sen · Ohio State University · R01 · FY2025 · CA
Engineered hybrid aging model for disease progression
$462,702Pinar Zorlutuna · University Of Notre Dame · R01 · FY2025 · CA
Modeling immunity with a hybrid lymph node tissue-chip
$462,626Rebecca R Pompano · University Of Virginia · R01 · FY2020 · AI
Interactions between the tumor cells and the neuro-immune microenvironment in mutant IDH1 gliomas: implications for therapeutics
$462,618Maria G Castro · University Of Michigan At Ann Arbor · R01 · FY2018 · NS
Mechanisms and Vulnerabilities of SWI/SNF chromatin remodeling complex mutant lung cancer
$462,600Yonathan Lissanu · University Of Tx Md Anderson Can Ctr · R37 · FY2023 · CA
Project 3
$462,573Charles J Rosser · Cedars-Sinai Medical Center · U54 · FY2022 · CA
Defining epigenetic signaling to reshape pancreatic tumor microenvironment
$462,567Jiaqi Shi · University Of Michigan At Ann Arbor · R37 · FY2022 · CA
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells
$462,546Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · CA
High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer
$462,518Dolores Di Vizio · Cedars-Sinai Medical Center · R01 · FY2017 · CA
Training in Cellular & Molecular Mechanisms of Tumor Rejection
$462,505Olivera J Finn · University Of Pittsburgh At Pittsburgh · T32 · FY2011 · CA
Function of IL35+ B cells in pancreatic cancer
$462,460Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2019 · CA
Targeting the EGFR-PI3K/mTOR Signaling Circuitry: A Network-Based Approach for Oral Cancer Precision Therapy
$462,426J. Silvio Gutkind · University Of California, San Diego · R01 · FY2022 · DE
Mechanical Regulation of Tumor Angiogenesis
$462,422Cynthia A Reinhart-King · Vanderbilt University · R01 · FY2019 · HL
Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer
$462,419Justin Pritchard · Pennsylvania State University, The · U01 · FY2021 · CA
Fatty acid signaling in the pancreatic tumor microenvironment
$462,414Mara H. Sherman · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Targeting Stromal Influences on Glutamine Addiction in Ovarian Cancer
$462,390Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Chemical Exchange Saturation Transfer (CEST) MRI for the Characterization Small Renal Masses
$462,317Elena Vinogradov · Ut Southwestern Medical Center · R01 · FY2023 · CA
Discovery of novel PCFT-targeted agents
$462,299Larry H. Matherly · Wayne State University · R01 · FY2011 · CA
Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
$462,269Donald W. Kufe · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Targeting innate immune pathways in breast cancers with chromosomal instability
$462,250Samuel F Bakhoum · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
Targeting innate immune pathways in breast cancers with chromosomal instability
$462,250Samuel F Bakhoum · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
$462,168Chi V. Dang · Johns Hopkins University · R01 · FY2022 · CA
Understanding the induction of T cell dysfunction in the context of lung cancer
$462,141Stefani Spranger · Massachusetts Institute Of Technology · R37 · FY2025 · CA